2018

The Long Tail of Oncogenic Drivers in Prostate Cancer Nature Genetics. 2018 April

  • Armenia J, Wankowicz SAM, Liu D, Gao J, Kundra R, Reznik E, Chatila WK, Chakravarty D, Han GC, Coleman I, Montgomery B, Pritchard C, Morrissey C, Barbieri CE, Beltran H, Sboner A, Zafeiriou Z, Miranda S, Bielski CM, Penson AV, Tolonen C, Huang FW, Robinson D, Wu YM, Lonigro R, Garraway LA, Demichelis F, Kantoff PW, Taplin ME, Abida W, Taylor BS, Scher HI, Nelson PS, de Bono JS, Rubin MA, Sawyers CL, Chinnaiyan AM

SPOP Mutation Drives Prostate Neoplasia Without Oncogenic Transcription Factor ERG The Journal of Clinical Investigation. 2018 January

  • Shoag J, Liu D, Blattner M, Sboner A, Park K, Deonarine L, Robinson BD, Mosquera JM, Chen Y, Rubin MA, Barbieri CE

The Role of Gut Microbiome in the Pathogenesis of Prostate Cancer: A Prospective, Pilot Study Urology. 2018 January

  • Golombos DM, Ayangbesan A, O'Malley P, Lewicki P, Barlow L, Barbieri CE, Chan C, DuLong C, Abu-Ali G, Huttenhower C, Scherr DS

2017

Vasectomy and Risk of Prostate Cancer in a Screening Trial Cancer Epidemiol Biomarkers. 2017 November

  • Shoag J, Savenkov O, Christos PJ, Mittal S, Halpern JA, Askin G, Shoag D, Golan R, Lee DJ, O'Malley P, Najari B, Eisner B, Hu JC, Scherr D, Schlegel P, Barbieri CE

Quantification of Mutant SPOP Proteins in Prostate Cancer Using Mass Spectrometry-based Targeted Proteomics Journal of Translation Medicine. 2017 Aug

  • Wang H, Barbieri CE, He J, Gao Y, Shi T, Wu C, Schepmoes AA, Fillmore TL, Chae SS, Huang D, Mosquera JM, Qian WJ, Smith RD, Srivastava S, Kagan J, Camp DG 2nd, Rodland KD, Rubin MA, Liu T

Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4 Nature Medicine. 2017 September

  • Dai X, Gan W, Li X, Wang S, Zhang W, Huang L, Liu S, Zhong Q, Guo J, Zhang J, Chen T, Shimizu K, Beca F, Blattner M, Vasudevan D, Buckley DL, Qi J, Buser L, Liu P, Inuzuka H, Beck AH, Wang L, Wild PJ, Garraway LA, Rubin MA, Barbieri CE, Wong KK, Muthuswamy SK, Huang J, Chen Y, Bradner JE, Wei W

Molecular alterations in prostate cancer and association with MRI features Prostate Cancer and Prostatic Diseases. 2017 August

  • Lee D, Fontugne J, Gumpeni N, Park K, MacDonald TY, Robinson BD, Sboner A, Rubin MA, Mosquera JM, Barbieri CE

Erratum to: Unraveling the clonal hierarchy of somatic genomic aberrations *Genome Biology. 2017 May

  • Prandi D, Baca SC, Romanel A, Barbieri CE, Mosquera JM, Fontugne J, Beltran H, Sboner A, Garraway LA, Rubin MA, Demichelis F

Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition European Urology. 2017 October

  • Dutta A, Panja S, Virk RK, Kim JY, Zott R, Cremers S, Golombos DM, Liu D, Mosquera JM, Mostaghel EA, Barbieri CE, Mitrofanova A, Abate-Shen C

SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling Cancer Cell. 2017 March

  • Blattner M, Liu D, Robinson BD, Huang D, Poliakov A, Gao D, Nataraj S, Deonarine LD, Augello MA, Sailer V, Ponnala L, Ittmann M, Chinnaiyan AM, Sboner A, Chen Y, Rubin MA, Barbieri CE

Prognostic Significance of a Negative Prostate Biopsy: An Analysis of Subjects Enrolled in a Prostate Cancer Screening Trial Journal of Urology. 2017 April

  • Lewicki P, Shoag J, Golombos DM, Oromendia C, Ballman KV, Halpern JA, Stone BV, O'Malley P, Barbieri CE, Scherr DS

DNA Repair in Prostate Cancer: Biology and Clinical Implications European Urology. 2017 March

  • Mateo J, Boysen G, Barbieri CE, Bryant HE, Castro E, Nelson PS, Olmos D, Pritchard CC, Rubin MA, de Bono JS

The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven Therapeutics European Urology. 2017 February

  • Barbieri CE, Chinnaiyan AM, Lerner SP, Swanton C, Rubin MA

Prostate size, nocturia and the digital rectal examination: a cohort study of 30 500 men Functional Urology. 2017 January

  • Stone BV, Shoag J, Halpern JA, Mittal S, Lewicki P, Golombos DM, Bedretdinova D, Chughtai B, Barbieri CE, Lee RK

2012-2016

Lethal Prostate Cancer in the PLCO Cancer Screening Trial European Urology. 2016 July

  • Shoag J, Mittal S, Halpern JA, Scherr D, Hu JC, Barbieri CE

SPOP mutation leads to genomic instability in prostate cancer eLife. 2015 September

  • Boysen G, Barbieri CE, Prandi D, Blattner M, Chae SS, Dahija A, Nataraj S, Huang D, Marotz C, Xu L, Huang J, Lecca P, Chhangawala S, Liu D, Zhou P, Sboner A, de Bono JS, Demichelis F, Houvras Y, Rubin MA

Genomic Rearrangements in Prostate Cancer Current Opinion in Urology. 2015 January

  • Barbieri CE, Rubin MA

SPOP Mutation in Prostate Cancer across Demographically Diverse Patient Cohorts Neoplasia. 2014 January

  • Blattner M, Lee DJ, O'Reilly C, Park K, MacDonald TY, Khani F, Turner KR, Chiu YL, Wild PJ, Dolgalev I, Heguy A, Sboner A, Ramazangolu S, Hieronymus H, Sawyers C, Tewari AK, Moch H, Yoon GS, Known YC, Andrén O, Fall K, Demichelis F, Mosquera JM, Robinson BD, Barbieri CE, Rubin MA

Exome Sequencing Identifies Recurrent SPOP, FOXA1, and MED12 Mutations in Prostate Cancer Nature Genetics. 2012 May

  • Barbieri CE, Baca SC, Lawrence MS, Demichelis F, Blattner M, Theurillat JP, White TA, Stojanov P, Van Allen E, Stransky N, Nickerson E, Chae SS, Boysen G, Auclair D, Onofrio RC, Park K, Kitabayashi N, MacDonald TY, Sheikh K, Vuong T, Guiducci C, Cibulskis K, Sivachenko A, Carter SL, Saksena G, Voet D, Hussain WM, Ramos AH, Winckler W, Redman MC, Ardlie K, Tewari AK, Mosquera JM, Rupp N, Wild PJ, Moch H, Morrissey C, Nelson PS, Kantoff PW, Gabriel SB, Golub TR, Meyerson M, Lander ES, Getz G, Rubin MA, Garraway LA

For a full list of publications, refer to this PubMed Link